Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?
09:56am, Monday, 04'th Aug 2025
JNJ lifts 2025 sales and EPS outlook on strong Q2 results, with new drug launches and MedTech gains fueling momentum.
The 3 Things That Matter for Johnson & Johnson Now
04:09am, Saturday, 02'nd Aug 2025
Johnson & Johnson (JNJ 1.57%) is one of the world's largest healthcare companies by market capitalization. The drugmaker has diversified operations, generating consistent revenue and profits.
3 Medical Stocks to Consider as Markets Take a Breather
06:01pm, Friday, 01'st Aug 2025
These top medical stocks may be able to provide defensive safety after President Trump's tariff hikes and July's unfavorable jobs report led to a market selloff.
4 Very Safe Dividend Stocks on Goldman Sachs' August Conviction Buy List
02:44pm, Friday, 01'st Aug 2025
Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest U.S.
Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.
JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?
11:41am, Friday, 01'st Aug 2025
JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.
Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb
08:31am, Friday, 01'st Aug 2025
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo
Buy 5 Wide Moat Stocks to Enhance Your Portfolio Returns
08:16am, Friday, 01'st Aug 2025
Boost your portfolio with ADBE, DIS, INTU, ROL and JNJ as these five wide moat stocks poised for growth and strong returns.
President Trump demands drugmakers slash prices within 60 days
06:54am, Friday, 01'st Aug 2025
CNBC's Joe Kernen reports on the latest news.
Trump pressures 17 pharma CEOs to cut US drug prices
02:28pm, Thursday, 31'st Jul 2025
U.S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans, the White House sa
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
01:48pm, Thursday, 31'st Jul 2025
President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days. It comes after Trump in May signed an executive order reviving a cont
Johnson & Johnson to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
04:32pm, Wednesday, 30'th Jul 2025
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10th, 2025. Management will part
Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case
07:11pm, Tuesday, 29'th Jul 2025
BOSTON--(BUSINESS WIRE)--A Boston jury has sided with Paul and Kathryn Lovell in a lawsuit against cosmetic behemoth Johnson & Johnson (NYSE:JNJ) that asserted Mr. Lovell's mesothelioma was directly c
Early VIRTUGUIDE™ surgeons report a 30-minute reduction in surgical time versus traditional treatment1 ,2 , *,** WEST CHESTER, Penn. , July 29, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) –
Submission is supported by 24-week results from the Phase 3b APEX study in adults with active psoriatic arthritis treated with TREMFYA ® , the only dual-acting IL-23 inhibitor HORSHAM, Pa. , J
